• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过肺表面活性剂以及磷脂十六醇吐温80,经Calu-3单层细胞增强重组人胰岛素的肺部吸收。

Enhanced pulmonary absorption of recombinant human insulin by pulmonary surfactant and phospholipid hexadecanol tyloxapol through Calu-3 monolayers.

作者信息

Zheng Jianheng, Zheng Yi, Chen Jiayin, Fang Fang, He Jiake, Li Ning, Tang Yue, Zhu Jiabi, Chen Xijing

机构信息

Key Laboratory of General Administration of Sport, Shanghai Research Institute of Sports Science, Shanghai, China.

出版信息

Pharmazie. 2012 May;67(5):448-51.

PMID:22764580
Abstract

Natural pulmonary surfactant (PS) and its artificial substitute phospholipid hexadecanol tyloxapol (PHT) are effective absorption enhancers on promoting recombinant human insulin (Rh-ins) absorption in vivo, but the in vitro efficacy and underlying mechanism remains unclear. In the current study, the permeation promoting effects of PS and PHT of insulin through Calu-3 monolayers in Transwell were evaluated. The viability of Calu-3 cells on conducting the permeation study was confirmed by TER and Electron Microscopy. Both PS and PHT significantly enhanced the permeation of Rh-ins and FD4 through calu-3 cells, with PS having a greater absorption enhancing effect than that of PHT. PS and PHT may interact directly with the tight junctions between cells and then result in intercellular permeation of peptide drugs. LDH release assay showed no significant acute toxicity of PS and PHT. The results indicated that these absorption enhancing agents may be useful as an absorption enhancer for pulmonary delivery of peptide and protein drugs.

摘要

天然肺表面活性剂(PS)及其人工替代品磷脂十六醇泰洛沙泊(PHT)是促进重组人胰岛素(Rh-ins)体内吸收的有效吸收促进剂,但体外疗效及潜在机制尚不清楚。在本研究中,评估了PS和PHT对胰岛素透过Transwell中Calu-3单层细胞的渗透促进作用。通过跨上皮电阻(TER)和电子显微镜确认了进行渗透研究时Calu-3细胞的活力。PS和PHT均显著增强了Rh-ins和FD4透过Calu-3细胞的渗透,PS的吸收增强作用比PHT更大。PS和PHT可能直接与细胞间紧密连接相互作用,进而导致肽类药物的细胞间渗透。乳酸脱氢酶(LDH)释放试验表明PS和PHT无明显急性毒性。结果表明,这些吸收促进剂可能作为肽和蛋白质药物肺部给药的吸收促进剂。

相似文献

1
Enhanced pulmonary absorption of recombinant human insulin by pulmonary surfactant and phospholipid hexadecanol tyloxapol through Calu-3 monolayers.通过肺表面活性剂以及磷脂十六醇吐温80,经Calu-3单层细胞增强重组人胰岛素的肺部吸收。
Pharmazie. 2012 May;67(5):448-51.
2
Effect of pulmonary surfactant and phospholipid hexadecanol tyloxapol on recombinant human-insulin absorption from intratracheally administered dry powders in diabetic rats.肺表面活性物质和磷脂十六醇聚氧乙烯醚对糖尿病大鼠气管内给药干粉中重组人胰岛素吸收的影响。
Chem Pharm Bull (Tokyo). 2010 Dec;58(12):1612-6. doi: 10.1248/cpb.58.1612.
3
Spermined dextran, a cationized polymer, as absorption enhancer for pulmonary application of peptide drugs.精胺化葡聚糖,一种阳离子化聚合物,作为肽类药物肺部应用的吸收促进剂。
Pharmazie. 2008 Mar;63(3):180-4.
4
Effects of sperminated polymers on the pulmonary absorption of insulin.发芽聚合物对胰岛素肺部吸收的影响。
J Control Release. 2008 Feb 11;125(3):246-51. doi: 10.1016/j.jconrel.2007.10.017. Epub 2007 Oct 26.
5
Artificial pulmonary surfactant as a carrier for intratracheally instilled insulin.人工肺表面活性剂作为气管内注入胰岛素的载体。
Acta Pharmacol Sin. 2007 May;28(5):744-50. doi: 10.1111/j.1745-7254.2007.00513.x.
6
[Effects of sperminated pullulans on the pulmonary absorption of insulin].[发芽普鲁兰多糖对胰岛素肺部吸收的影响]
Yakugaku Zasshi. 2011 Feb;131(2):307-14. doi: 10.1248/yakushi.131.307.
7
Evaluation of inhaled recombinant human insulin dry powders: pharmacokinetics, pharmacodynamics and 14-day inhalation.吸入用重组人胰岛素干粉制剂的评价:药代动力学、药效学和 14 天吸入研究。
J Pharm Pharmacol. 2019 Feb;71(2):176-184. doi: 10.1111/jphp.13026. Epub 2018 Oct 15.
8
The preparation and application of pulmonary surfactant nanoparticles as absorption enhancers in insulin dry powder delivery.肺表面活性剂纳米粒作为胰岛素干粉递药吸收促进剂的制备与应用。
Drug Dev Ind Pharm. 2009 Sep;35(9):1059-65. doi: 10.1080/03639040902769628.
9
Impact of amino acid replacements on in vitro permeation enhancement and cytotoxicity of the intestinal absorption promoter, melittin.氨基酸取代对肠吸收促进剂蜂毒素体外渗透增强和细胞毒性的影响。
Int J Pharm. 2010 Mar 15;387(1-2):154-60. doi: 10.1016/j.ijpharm.2009.12.022. Epub 2009 Dec 16.
10
Evaluation of insulin permeability and effects of absorption enhancers on its permeability by an in vitro pulmonary epithelial system using Xenopus pulmonary membrane.使用非洲爪蟾肺膜的体外肺上皮系统评估胰岛素渗透性及吸收促进剂对其渗透性的影响。
Biol Pharm Bull. 2001 Apr;24(4):385-9. doi: 10.1248/bpb.24.385.

引用本文的文献

1
Evaluation of Drug Permeation Enhancement by Using In Vitro and Ex Vivo Models.使用体外和离体模型评估药物渗透增强作用
Pharmaceuticals (Basel). 2025 Jan 31;18(2):195. doi: 10.3390/ph18020195.
2
Respiratory delivered vaccines: Current status and perspectives in rational formulation design.呼吸道给药疫苗:合理剂型设计的现状与展望
Acta Pharm Sin B. 2024 Dec;14(12):5132-5160. doi: 10.1016/j.apsb.2024.08.026. Epub 2024 Nov 4.
3
Pulmonary Delivery of Biological Drugs.生物药物的肺部给药
Pharmaceutics. 2020 Oct 26;12(11):1025. doi: 10.3390/pharmaceutics12111025.
4
Strategies to Enhance Drug Absorption via Nasal and Pulmonary Routes.通过鼻腔和肺部途径增强药物吸收的策略。
Pharmaceutics. 2019 Mar 11;11(3):113. doi: 10.3390/pharmaceutics11030113.
5
Challenges and Future Prospects for the Delivery of Biologics: Oral Mucosal, Pulmonary, and Transdermal Routes.生物制剂递送的挑战与未来前景:口腔黏膜、肺部和透皮途径
AAPS J. 2017 May;19(3):652-668. doi: 10.1208/s12248-017-0054-z. Epub 2017 Feb 13.